Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 401

1.

Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease.

Ikeda A, Gabazza EC, Morser J, Imoto I, Kuroda M, D'Alessandro-Gabazza CN, Hara K, Ruiz DB, Bernabe PG, Katsurahara M, Toda M, Kobayashi Y, Yano Y, Sumida Y, Suzuki K, Taguchi O, Takei Y.

Helicobacter. 2009 Apr;14(2):147-55. doi: 10.1111/j.1523-5378.2009.00662.x.

PMID:
19298343
2.

Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection.

Colucci M, Rossiello MR, Pentimone A, Berloco P, Russo F, Di Leo A, Semeraro N.

Thromb Res. 2005;116(6):471-7.

PMID:
16181982
4.

Vacuolating cytotoxin A is associated with increased thrombin generation in gastric mucosa.

Suzuki Y, Gabazza EC, Imoto I, James RF, Hirayama T, Wada A, Horiki N, Nakamura M, Inoue H, Kuroda M, Ogura A, Taguchi Y, Yano Y, Taguchi O, Suzuki K, Adachi Y.

Helicobacter. 2005 Aug;10(4):323-31.

PMID:
16104949
5.

New acquisitions in Helicobacter pylori infection. Introduction.

Gasbarrini G, Gasbarrini A.

Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S243. Review. No abstract available.

PMID:
10077745
6.

The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: role of asymmetric dimethylarginine.

Zhang Z, Zou YY, Zhou Y, Zhou H, Li YJ.

J Clin Gastroenterol. 2009 Mar;43(3):261-6. doi: 10.1097/MCG.0b013e3181624485.

PMID:
18936714
7.

Prevalence and heterogeneity of Helicobacter pylori in gastric biopsies of patients with gastroduodenal diseases.

Lin CW, Chang YS, Lai PY, Cheng KS.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1997 May;30(2):61-71.

PMID:
10592812
8.

Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

Bouma BN, Mosnier LO.

Ann Med. 2006;38(6):378-88. Review.

PMID:
17008302
9.

[Helicobacter pylori and gastroduodenal disease in our patients: 2-year experience].

Brigić E, Hodzić L, Zildzić M.

Med Arh. 2000;54(5-6):313-6. Croatian.

PMID:
11219914
10.

Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection.

Ma N, Adachi Y, Hiraku Y, Horiki N, Horiike S, Imoto I, Pinlaor S, Murata M, Semba R, Kawanishi S.

Biochem Biophys Res Commun. 2004 Jun 25;319(2):506-10.

PMID:
15178435
11.

Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities.

Wu MS, Chow LP, Lin JT, Chiou SH.

J Gastroenterol Hepatol. 2008 Nov;23(11):1657-61. doi: 10.1111/j.1440-1746.2008.05659.x. Review.

PMID:
19120858
13.

Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients.

Akinci B, Comlekci A, Yener S, Demir T, Ozcan MA, Bayraktar F, Yesil S.

Endocr J. 2007 Aug;54(4):593-9. Epub 2007 Aug 10.

14.

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.

Zorio E, Castelló R, Falcó C, España F, Osa A, Almenar L, Aznar J, Estellés A.

Br J Haematol. 2003 Sep;122(6):958-65.

PMID:
12956767
15.

Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors.

Juhan-Vague I, Renucci JF, Grimaux M, Morange PE, Gouvernet J, Gourmelin Y, Alessi MC.

Arterioscler Thromb Vasc Biol. 2000 Sep;20(9):2156-61.

16.

Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.

Wex T, Kuester D, Vieth M, Treiber G, Krieg A, Roessner A, Malfertheiner P.

Scand J Gastroenterol. 2008;43(10):1194-201. doi: 10.1080/00365520802158598.

PMID:
18609127
17.

Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model.

Mita M, Satoh M, Shimada A, Okajima M, Azuma S, Suzuki JS, Sakabe K, Hara S, Himeno S.

Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G877-84. doi: 10.1152/ajpgi.00251.2007. Epub 2008 Jan 31.

18.

[UreI: a Helicobacter pylori protein essential for resistance to acidity and for the early steps of murine gastric mucosa infection].

Bury-Moné S, Skouloubris S, Labigne A, De Reuse H.

Gastroenterol Clin Biol. 2001 Jun-Jul;25(6-7):659-63. French.

19.

Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.

Kitagawa N, Yano Y, Gabazza EC, Bruno NE, Araki R, Matsumoto K, Katsuki A, Hori Y, Nakatani K, Taguchi O, Sumida Y, Suzuki K, Adachi Y.

Diabetes Res Clin Pract. 2006 Aug;73(2):150-7. Epub 2006 Feb 3.

PMID:
16458385
20.

Cultured human gastric explants: a model for studies of bacteria-host interaction during conditions of experimental Helicobacter pylori infection.

Olfat FO, Näslund E, Freedman J, Borén T, Engstrand L.

J Infect Dis. 2002 Aug 1;186(3):423-7. Epub 2002 Jul 17.

PMID:
12134241

Supplemental Content

Support Center